Back to Market Feed

TREMFYA 200 MG/2 ML PEN

guselkumab
$7349.6700per ML

Strength

200 mg/2mL

NDC

57894065102

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

2/3/2026

Active Ingredients

GUSELKUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761061

On Market Since

9/11/2024

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+5.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14766.3280
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14769.7353
per ML
SKYRIZI 150 MG/ML PEN
Brand
00074210001•AbbVie Inc.
$22807.6858
per ML
SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22942.3716
per ML
STELARA 90 MG/ML SYRINGE
Brand
57894006103•Janssen Biotech, Inc.
$29794.5447
per ML
STELARA 45 MG/0.5 ML SYRINGE
Brand
57894006003•Janssen Biotech, Inc.
$29841.6480
per ML